J. Alan Crunkleton, PhD, MD
President, CEO, Director
Alan Crunkleton has led Correx since cofounding the company in 2004. His background combines medical training with 15 years of entrepreneurial experience and 30 years in both academic and commercial research and development. With this background, Dr. Crunkleton contributes a unique understanding of both the market and the technologies under development, enabling effective communication in both arenas to meet goals and objectives for commercialization and clinical adoption.
Prior to his position at Correx, Dr. Crunkleton cofounded Boreas, Inc., a venture capital-backed, cryogenic refrigeration company, serving as President and CEO. He earned a medical degree at the University of Massachusetts Medical School in 2002. Dr. Crunkleton holds M.S. and Ph.D. degrees in mechanical engineering from the Massachusetts Institute of Technology (MIT). He holds several patents, medical and nonmedical. Dr. Crunkleton is a coauthor of the patent for the Correx 18 MM AVB Kit.
Joel B. Braunstein, MD, MBA, FACC
Dr. Joel Braunstein is a cofounder and managing partner of LifeTech Development Partners, a lead investor in Correx. He is also cofounder and CEO of LifeTech Research, a life sciences investment research firm formed in 2003; cofounder and Chairman of Centegen, Inc.; cofounder and board member of C2N Diagnostics; and board member of Nexgen Medical Systems and Tivorsan Pharmaceuticals.
Dr. Braunstein is a board certified cardiologist and internist. In his clinical capacity, Dr. Braunstein is affiliated with Yale University School of Medicine and the Yale Center for Outcomes Research and Evaluations.
Clinical Affairs Manager
Steve Coache joined Correx in early 2011. Mr. Coache has more than 12 years of international experience in the commercial introduction and clinical advancement of medical device products and related clinical procedures. He is responsible for clinical set up and surgeon training for the Correx product and the Correx AVB procedure. In addition, Mr. Coache is leading the implementation of clinical and pre-clinical studies in support of Correx AVB.
Prior to joining Correx, Mr. Coache served as Clinical Program Manager at Viacor Inc. where he assumed responsibility for preparation of all clinical and pre-clinical events. Mr. Coache also worked at NDO Surgical, a venture capital backed medical device start-up company, in the positions of International Business Development Specialist and Senior Physician Training Specialist.
Joseph L. Smith, Jr., ScD
Professor Smith was a world-renowned expert in the fields of cryogenic refrigeration, applied thermodynamics and superconductivity. He was a Professor of Mechanical Engineering at the Massachusetts Institute of Technology (MIT) from 1964 until 2013, the year of his passing. Professor Smith ran the Cryogenic Engineering Laboratory at MIT until 2008. He had served as an advisor to early-stage ventures and as a consultant to major corporations. Professor Smith was a cofounder of Correx and a coauthor of the patent for the Correx AVB 18MM Kit. He held many patents, both nonmedical and medical.